IQE photonics segment revenue build by customer/product (£M)

FY2025 actuals estimated from H1 2025 RNS (photonics £26.6M H1) and Q1 2026 order book commentary. FY2026 onward is Shawarma Capital base case projection. Quintessent CPO ramp assumes commercial scale from FY2027. MACOM LTSA ramp assumes progressive volume commitment.
Chart: Shawarma CapitalSource: IQE H1 2025 RNS, IQE January 2026 trading update, Quintessent partnership RNS, Shawarma Capital modelGet the data Download imageCreated with Datawrapper